DEBIOPHARM GROUP
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
DEBIOPHARM GROUP
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1979-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.debiopharm.com
Total Employee:
251+
Status:
Active
Contact:
+41213210111
Total Funding:
4.7 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-02-11 | Affinium Pharmaceuticals | Affinium Pharmaceuticals acquired by Debiopharm Group | N/A |
Investors List
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-09 | Novadiscovery | Debiopharm Group investment in Series A - Novadiscovery | 5 M EUR |
| 2019-11-10 | Little Green House | Debiopharm Group investment in Corporate Round - Little Green House | N/A |
| 2016-10-26 | Coorpacademy | Debiopharm Group investment in Series B - Coorpacademy | 10 M EUR |
| 2015-04-03 | Immunexpress | Debiopharm Group investment in Debt Financing - Immunexpress | 40 M USD |
| 2014-11-17 | Coorpacademy | Debiopharm Group investment in Series A - Coorpacademy | 3.2 M EUR |
| 2014-05-05 | Immunexpress | Debiopharm Group investment in Series B - Immunexpress | 18 M USD |
| 2014-03-05 | Immunexpress | Debiopharm Group investment in Funding Round - Immunexpress | 6 M USD |
| 2013-12-03 | BPA Solutions | Debiopharm Group investment in Funding Round - BPA Solutions | N/A |
| 2013-09-06 | Skioo | Debiopharm Group investment in Venture Round - Skioo | N/A |
| 2013-05-22 | Urturn | Debiopharm Group investment in Series A - Urturn | 13.4 M USD |
Newest Events participated
Participated in Swiss Startup Day
on 2015-10-21 as sponsor
Official Site Inspections
http://www.debiopharm.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.93 K
- Host name: havps24.iron.bsa.oriented.ch
- IP address: 185.15.230.34
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Debiopharm Group"
Debiopharm - Wikipedia
Debiopharm is known for the development of triptorelin and oxaliplatin, two drugs that became standards of care for the treatment of various types of cancer and are listed on the World Health Organization's List of Essential Medicines. • Triptorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) approved for several indications, including prostate cancer and endometriosis, under the names Decapeptyl, Neo Dec…See details»
Leadership Team - Debiopharm
Debiopharm, with 15 ongoing drug research programs, has developed two blockbuster therapies for cancer patients, oxaliplatin and triptorelin, along with a potential 3rd Head & Neck Cancer …See details»
Debiopharm Group - Crunchbase Company Profile
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their …See details»
Our Growing Expertise in Antibiotics - Debiopharm
Since 2014, we have been actively involved in the in-licensing and development of promising anti-infective compounds. With workforce with over 20 years of experience in the optimization of antimicrobial agents at Debiopharm, in …See details»
Corporate Responsibility - Debiopharm
At Debiopharm through corporate responsibility we aim to positively contribute to society and the environment.See details»
Debiopharm Group - Financial Details - Crunchbase
Oct 19, 2021 Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.See details»
Drug Development - Debiopharm
Debiopharm is an innovation-focused, Swiss biopharmaceutical company that aims to develop novel therapies to target high unmet medical needs in oncology and infectious diseases. We establish partnerships with academic, biotech, …See details»
Welcome to our new website - Debiopharm
Oct 2, 2018 You can now choose if you would like to know more about Debiopharm International, Debiopharm Research & Manufacturing, Debiopharm Innovation Fund, Debiopharm Investment or GenePOC. If you scroll down the …See details»
Debiopharm - Org Chart, Teams, Culture & Jobs | The …
View Debiopharm's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Debiopharm — Wikipédia
Debiopharm Research & Manufacturing Debiopharm Research & Manufacturing, précédemment appelée Debio R.P. et basée à Martigny, est à la fois un laboratoire de recherche appliquée …See details»
Debiopharm Innovation Fund — OBIO - Ontario Bioscience …
Jul 29, 2025 Debiopharm Innovation Fund This fund is the strategic corporate venture arm of the Swiss biopharmaceutical company, Debiopharm. With a fund size of $150 million, it invests in …See details»
Debiopharm - LinkedIn
Debiopharm | 39,718 followers on LinkedIn. we develop for patients | Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential …See details»
Debiopharm - HQ | The Org
Debiopharm's headquarters in Lausanne, SwitzerlandSee details»
Debiopharm Innovation Fund - Crunchbase Company Profile
Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.See details»
Debiopharm – Wikipedia
Debiopharm ist ein Pharmaunternehmen mit Sitz in Lausanne. Es konzentriert sich auf die klinische Entwicklung sowie die Fertigung von Arzneien. Das 1979 gegründete …See details»
Debiopharm
About: Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then …See details»
Debiopharm International SA - Swiss Biotech
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial …See details»
Debiopharm - Craft
Debiopharm has 5 employees across 2 locations and $2.1 m in total funding,. See insights on Debiopharm including office locations, competitors, revenue, financials, executives, …See details»
We develop for patients – Debiopharm – Clinical trials
Debiopharm strongly believe that patients can be actors in their own medical care and does its best to make it as simple as possible for them.See details»
Debiopharm - Overview, News & Similar companies | ZoomInfo.com
View Debiopharm (www.debiopharm.com) location in Vaud, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»